Nektar Therapeutics reported 0 in Dividend Yield for its fiscal quarter ending in March of 2025.





Dy Change Date
Alterity Therapeutics Limited AUD 0 0 Dec/2024
Amgen 2.71 0.08 Jun/2026
Baxter International 0.14 2 Jun/2026
BioCryst Pharmaceuticals 0 0 Mar/2025
Bristol-Myers Squibb 4.36 0.23 Jun/2026
Cara Therapeutics 0 0 Mar/2025
Cipla 0.89 0.18 Jun/2026
Dr.Reddys Laboratories 0.59 0.05 Jun/2026
Eisai 3.88 0.6 Jun/2026
Eli Lilly 0.56 0.02 Jun/2026
Gilead Sciences 2.55 0.26 Jun/2026
GlaxoSmithKline 0.86 0.03 Jun/2026
Grifols EUR 1.88 0.68 Dec/2025
Karyopharm Therapeutics 0 0 Mar/2025
Merck 2.62 0.14 Jun/2026
Nektar Therapeutics 0 0 Mar/2025
Novartis USD 3.1 0.23 Jun/2026
Pfizer 7.08 0.72 Jun/2026
Roche Holding 2.94 0.01 Jun/2026
Takeda 3.88 2.23 Jun/2026